Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals

Cyclacel is a biopharmaceutical company, based in Berkeley Heights, New Jersey and Dundee, Scotland, that develops orally available small molecule drugs which target various cell cycle phases to control cancer and other serious diseases..
Raised
$15.2M
Follow us
Alexa global traffic share
Latest funding
$15,200,000
Post-IPO equity - 2017
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Cyclacel Pharmaceuticals makes some noise.